Mette Sannes
Position:
Phone:
Email:
 

Author network for Mette Sannes by COREMINE medical


Publications 2014

Olson AD, Guiguet M, Zangerle R, Gill J, Perez-Hoyos S, Lodi S, Ghosn J, Dorrucci M, Johnson A, Sannes M, Moreno S, Porter K, for CASCADE Collaboration in EuroCoord (2014)
Evaluation of rapid progressors in HIV infection as an extreme phenotype
J Acquir Immune Defic Syndr, 67 (1), 15-21
PubMed 24872130

Publications 2013

Madec Y, Boufassa F, Porter K, Prins M, Sabin C, d'Arminio Monforte A, Amornkul P, Bartmeyer B, Sannes M, Venet A, Lambotte O, Meyer L, CASCADE Collaboration in Eurocoord (2013)
Natural history of HIV-control since seroconversion
AIDS, 27 (15), 2451-60
PubMed 23912979

Publications 2012

Lodi S, Meyer L, Kelleher AD, Rosinska M, Ghosn J, Sannes M, Porter K (2012)
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
Arch Intern Med, 172 (16), 1252-5
PubMed 22826124

Publications 2011

van der Helm JJ, Prins M, del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill J, Hamouda O, Sannes M, Porter K, Geskus RB, CASCADE Collaboration (2011)
The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007
AIDS, 25 (8), 1083-91
PubMed 21537114

Publications 2009

Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
J Clin Microbiol, 47 (7), 2170-4
PubMed 19420166

Publications 2008

Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K, CASCADE Collaboration (2008)
Changes in the risk of death after HIV seroconversion compared with mortality in the general population
JAMA, 300 (1), 51-9
PubMed 18594040

Publications 2006

Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V (2006)
[HIV/AIDS--from lethal syndrome to chronic disease]
Tidsskr Nor Laegeforen, 126 (23), 3121-4
PubMed 17160119

Publications 2002

Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O et al. (2002)
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks
Int J Epidemiol, 31 (5), 951-8
PubMed 12435766

Dunlop O, Bjørklund R, Bruun JN, Evensen R, Goplen AK, Liestøl K, Sannes M, Maehlen J, Myrvang B (2002)
Early psychomotor slowing predicts the development of HIV dementia and autopsy-verified HIV encephalitis
Acta Neurol Scand, 105 (4), 270-5
PubMed 12004769

Publications 1999

Mugnaini EN, Haaheim LL, Sannes M, Brinchmann JE (1999)
In vivo expansion coincident with excessive in vitro cell death within the memory subset of CD8+ T cells in HIV type 1 infection
AIDS Res Hum Retroviruses, 15 (3), 265-72
PubMed 10052757

Mugnaini EN, Syversen AM, Sannes M, Freng A, Brinchmann JE (1999)
Normal CD4 T-cell receptor repertoire in tonsillar tissue despite perturbed repertoire in peripheral blood in HIV-1 infected individuals
AIDS, 13 (18), 2507-13
PubMed 10630519

Publications 1998

Mugnaini EN, Spurkland A, Egeland T, Sannes M, Brinchmann JE (1998)
Demonstration of identical expanded clones within both CD8+CD28+ and CD8+CD28- T cell subsets in HIV type 1-infected individuals
Eur J Immunol, 28 (5), 1738-42
PubMed 9603481

Publications 1996

Dunlop O, Rootwelt V, Sannes M, Goplen AK, Abdelnoor M, Skaug K, Baklien K, Skar A, Melby K, Myrvang B, Bruun JN (1996)
Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis
Scand J Infect Dis, 28 (1), 71-3
PubMed 9122637

Publications 1994

Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T (1994)
Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations
J Infect Dis, 169 (4), 730-8
PubMed 7907640